Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission

被引：11

作者：

Mischnik, Alexander ^{[1
,2
,11
]}

Baumert, Philipp ^{[1
,2
]}

Hamprecht, Axel ^{[1
,3
]}

Rohde, Anna ^{[1
,4
]}

Peter, Silke ^{[1
,5
]}

Feihl, Susanne ^{[1
,6
]}

Knobloch, Johannes ^{[1
,7
]}

Goelz, Hanna ^{[1
,8
]}

Kola, Axel ^{[1
,4
]}

Obermann, Birgit ^{[1
,9
]}

Querbach, Christiane ^{[1
,6
]}

Willmann, Matthias ^{[1
,5
]}

Gebhardt, Friedemann ^{[1
,6
]}

Tacconelli, Evelina ^{[1
,10
]}

Gastmeier, Petra ^{[1
]}

Seifert, Harald ^{[1
]}

Kern, Winfried V. ^{[1
,2
]}

机构：

[1] German Ctr Infect Res DZIF, Hannover, Germany

[2] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany

[3] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany

[4] Chari Univ Hosp Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Inst Hyg & Environm Med, Berlin, Germany

[5] Univ Tubingen, Inst Med Microbiol & Hygiene, Tubingen, Germany

[6] Tech Univ Munich, Inst Med Microbiol Immunol & Hygiene, Munich, Germany

[7] Univ Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hygiene, Hamburg, Germany

[8] Univ Med Ctr Freiburg, Inst Med Microbiol & Hygiene, Freiburg, Germany

[9] Univ Hosp Schleswig Holstein, Inst Med Microbiol, Lubeck, Germany

[10] Univ Hosp Tubingen, Dept Internal Med 1, Div Infect Dis, Tubingen, Germany

[11] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 49卷 / 02期

关键词：

Extended-spectrum beta-lactamase; ESBL; beta-Lactam; Avibactam; AmpC; IN-VITRO ACTIVITY; BETA-LACTAMASES; AVIBACTAM; COLONIZATION; CEFTAZIDIME; BACTEREMIA;

D O I：

10.1016/j.ijantimicag.2016.10.013

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

As part of the multicentre Antibiotic Therapy Optimisation Study (ATHOS), minimum inhibitory concentrations (MICs) were determined for cephalosporins alone and in combination with the beta-lactamase inhibitors tazobactam, clavulanic acid and avibactam against third-generation cephalosporin-resistant Escherichia coli, Klebsiella spp. and Enterobacter spp. isolates collected in German hospitals. MIC50/90 values were 0.254mg/L for cefepime/tazobactam, 0.25-2 mg/L for ceftazidime/avibactam, 0.125-0.5mg/L for ceftaroline/avibactam, 0.5-4 mg/L for cefpodoxime/clavulanic acid and 0.25-1 mg/L for aztreonam/avibactam, depending on the underlying resistance mechanism and organism. Based on in vitro testing, beta-lactam antibiotics play an important role in the treatment of infections due to beta-lactamase-producing organisms. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

引用

页码：239 / 242

页数：4

共 50 条

[1] Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
Mischnik, Alexander
Baumert, Philipp
Hamprecht, Axel
Rohde, Anna
Peter, Silke
Feihl, Susanne
Knobloch, Johannes
Goelz, Hanna
Kola, Axel
Obermann, Birgit
Querbach, Christiane
Willmann, Matthias
Gebhardt, Friedemann
Tacconelli, Evelina
Gastmeier, Petra
Seifert, Harald
Kern, Winfried V.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (01) : 71 - 73
[2] In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
Mischnik, A.
Baumert, P.
Hamprecht, A.
Rohde, A. M.
Peter, S.
Feihl, S.
Knobloch, J.
Goelz, H.
Kola, A.
Obermann, B.
Querbach, C.
Willmann, M.
Gebhardt, F.
Tacconelli, E.
Gastmeier, P.
Seifert, H.
Kern, W. V.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (05) : 1359 - 1363
[3] Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Africa
Asogwa, Ifunanya E.
ARCHIVES OF PHARMACY PRACTICE, 2018, 9 (01) : 1 - 2
[4] Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors
Hamprecht, A.
Rohde, A. M.
Behnke, M.
Feihl, S.
Gastmeier, P.
Gebhardt, F.
Kern, W. V.
Knobloch, J. K.
Mischnik, A.
Obermann, B.
Querbach, C.
Peter, S.
Schneider, C.
Schroeder, W.
Schwab, F.
Tacconelli, E.
Wiese-Posselt, M.
Wille, T.
Willmann, M.
Seifert, H.
Zweigner, J.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (10) : 2957 - 2963
[5] Risk factors for colonization with third-generation cephalosporin-resistant Enterobacteriaceae
Wendt, C
Lin, D
von Baum, H
INFECTION, 2005, 33 (5-6) : 327 - 332
[6] Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital
Boldt, Anne-Catherine
Schwab, Frank
Rohde, Anna M.
Kola, Axel
Bui, Minh Trang
Maertin, Nayana
Kipnis, Marina
Schroeder, Christin
Leistner, Rasmus
Wiese-Posselt, Miriam
Zweigner, Janine
Gastmeier, Petra
Denkel, Luisa A.
PLOS ONE, 2018, 13 (08):
[7] High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals
Rohde, Anna M.
Wiese-Posselt, Miriam
Zweigner, Janine
Schwab, Frank
Mischnik, Alexander
Seifert, Harald
Gastmeier, Petra
Kern, Winfried V.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (06) : 1688 - 1691
[8] Third-generation cephalosporin-resistant pneumococcal meningitis in children
Aiba, Hiroyuki
Shoji, Kensuke
Shinjo, Daisuke
Ishiguro, Akira
Miyairi, Isao
PEDIATRICS INTERNATIONAL, 2021, 63 (09) : 1133 - 1135
[9] Third-Generation Cephalosporin-Resistant Vibrio cholerae, India
Mandal, Jharna
Sangeetha, Vilwanathan
Ganesan, Vithiya
Parveen, Mohamudha
Preethi, Venkatesan
Harish, Belgode Narasimha
Srinivasan, Sampath
Parija, Subhash Chandra
EMERGING INFECTIOUS DISEASES, 2012, 18 (08) : 1326 - 1328
[10] Prevalence of colonisation with third-generation cephalosporin-resistant enterobacteriaceae in ICU patients of Heidelberg University Hospitals
von Baum, H
Lin, D
Wendt, C
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (05) : 436 - 440

← 1 2 3 4 5 →